FDA Asks Pfizer For More Data On Anti-Smoking Drug
By Christine Caulfield ( November 21, 2007, 12:00 AM EST) -- The U.S Food and Drug Administration said it had received reports of suicidal thoughts and erratic behavior in smokers taking Pfizer Inc's anti-smoking drug Chantix and has asked the pharmaceutical giant to produce more post-marketing data on the medication....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.